The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Ola Hansson

Ola Hansson

Principal investigator

Ola Hansson

Mapping the cord blood transcriptome of pregnancies affected by early maternal anemia to identify signatures of fetal programming

Author

  • Gad Hatem
  • Line Hjort
  • Olof Asplund
  • Daniel T R Minja
  • Omari Abdul Msemo
  • Sofie Lykke Møller
  • Thomas Lavstsen
  • Louise Groth-Grunnet
  • John P A Lusingu
  • Ola Hansson
  • Dirk Lund Christensen
  • Allan A Vaag
  • Isabella Artner
  • Thor Theander
  • Leif Groop
  • Christentze Schmiegelow
  • Ib Christian Bygbjerg
  • Rashmi B Prasad

Summary, in English

OBJECTIVE: Anemia during early pregnancy (EP) is common in developing countries and is associated with adverse health consequences for both mother and children. Offspring of women with EP anemia often have low birth-weight, the latter being a risk factor for cardiometabolic diseases including type 2 diabetes (T2D) later in life. Mechanisms underlying developmental programming of adult cardiometabolic disease include epigenetic and transcriptional alterations potentially detectable in umbilical cord blood (UCB) at time of birth.

METHODS: We leveraged global transcriptome- and accompanying epigenome-wide changes in 48 UCB from newborns of EP-anemic Tanzanian mothers and 50 controls to identify differentially expressed genes (DEG) in UCB exposed to maternal EP-anemia. DEGs were assessed for association with neonatal anthropometry and cord insulin levels. These genes were further studied in expression data from human fetal pancreas and adult islets to understand their role in beta-cell development and/or function.

RESULTS: The expression of 137 genes was altered in UCB of newborns exposed to maternal EP anemia. These putative signatures of fetal programming which included the birth-weight locus LCORL, were potentially mediated by epigenetic changes in 27 genes and associated with neonatal anthropometry. Among the DEGs were P2RX7, PIK3C2B, and NUMBL which potentially influence beta-cell development. Insulin levels were lower in EP anemia exposed UCB, supporting the notion of developmental programming of pancreatic beta-cell dysfunction and subsequently increased risk of T2D in offspring of EP anemic mothers.

CONCLUSIONS: Our data provide proof-of-concept on distinct transcriptional and epigenetic changes detectable in UCB from newborns exposed to maternal EP anemia.

Department/s

  • EXODIAB: Excellence of Diabetes Research in Sweden
  • Genomics, Diabetes and Endocrinology
  • Endocrine Cell Differentiation and Function
  • StemTherapy: National Initiative on Stem Cells for Regenerative Therapy

Publishing year

2022

Language

English

Pages

1303-1316

Publication/Series

The Journal of clinical endocrinology and metabolism

Volume

107

Issue

5

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology
  • Endocrine Cell Differentiation and Function

ISBN/ISSN/Other

  • ISSN: 1945-7197